EXC vs PLRX · P/E 17, rev $23.03B vs $77.3M cap
Exelon Corporation (EXC) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the EXC and PLRX stock pages for the full models.
Not investment advice.